Context Therapeutics Statistics

Total Valuation

CNTX has a market cap or net worth of $59.22 million. The enterprise value is -$29.94 million.

Market Cap	59.22M
Enterprise Value	-29.94M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CNTX has 89.70 million shares outstanding. The number of shares has increased by 389.92% in one year.

Current Share Class	89.70M
Shares Outstanding	89.70M
Shares Change (YoY)	+389.92%
Shares Change (QoQ)	+16.18%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	25.19%
Float	39.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.56
P/TBV Ratio	0.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 48.80, with a Debt / Equity ratio of 0.00.

Current Ratio	48.80
Quick Ratio	47.02
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -55.59% and return on invested capital (ROIC) is -39.69%.

Return on Equity (ROE)	-55.59%
Return on Assets (ROA)	-38.01%
Return on Invested Capital (ROIC)	-39.69%
Return on Capital Employed (ROCE)	-34.73%
Revenue Per Employee	n/a
Profits Per Employee	-$2.30M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.66% in the last 52 weeks. The beta is 1.86, so CNTX's price volatility has been higher than the market average.

Beta (5Y)	1.86
52-Week Price Change	-66.66%
50-Day Moving Average	0.73
200-Day Moving Average	1.19
Relative Strength Index (RSI)	52.30
Average Volume (20 Days)	374,172

Short Selling Information

The latest short interest is 1.72 million, so 1.92% of the outstanding shares have been sold short.

Short Interest	1.72M
Short Previous Month	2.23M
Short % of Shares Out	1.92%
Short % of Float	4.38%
Short Ratio (days to cover)	5.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.63M
Pretax Income	-18.57M
Net Income	-27.63M
EBITDA	-31.62M
EBIT	-31.63M
Earnings Per Share (EPS)	-$0.35

Full Income Statement

Balance Sheet

The company has $89.35 million in cash and $193,706 in debt, giving a net cash position of $89.16 million or $0.99 per share.

Cash & Cash Equivalents	89.35M
Total Debt	193,706
Net Cash	89.16M
Net Cash Per Share	$0.99
Equity (Book Value)	90.98M
Book Value Per Share	1.01
Working Capital	90.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.22 million and capital expenditures -$41,264, giving a free cash flow of -$15.27 million.

Operating Cash Flow	-15.22M
Capital Expenditures	-41,264
Free Cash Flow	-15.27M
FCF Per Share	-$0.17

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-389.92%
Shareholder Yield	-389.92%
Earnings Yield	-46.66%
FCF Yield	-25.78%

Analyst Forecast

The average price target for CNTX is $5.50, which is 733.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.50
Price Target Difference	733.08%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-40.55%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2